Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains one of the most crucial tools in contemporary anaesthesia and sharp pain management throughout the United Kingdom. As a potent synthetic opioid, its role in the National Health Service (NHS) and private surgical sectors is reputable, mainly due to its fast onset of action and cardiovascular stability. This post offers an extensive summary of fentanyl citrate injection formulas readily available in the UK, their medical signs, regulative landscape, and administration protocols.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was first synthesized in 1960 and quickly ended up being a foundation of perioperative care. In regards to effectiveness, fentanyl is roughly 50 to 100 times more powerful than morphine. Its high lipophilicity enables it to cross the blood-brain barrier rapidly, resulting in a nearly instant analgesic result when administered intravenously.
In the UK, fentanyl citrate is predominantly utilized through the parenteral path (injection) for both sedative and analgesic purposes. It works mainly by binding to the mu-opioid receptors in the central nerve system, altering the perception of discomfort and the psychological action to it.
Clinical Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is indicated for numerous specific medical scenarios:
- Analgesic Action: Used throughout short personnel treatments and in the healing space.
- Analgesic Supplement: Used during the induction and upkeep of inhalation anaesthesia.
- Neuroleptanalgesia: Often used in mix with a neuroleptic (such as droperidol) to achieve a state of quiescence and lowered awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To supply sedation and analgesia before the induction of general anaesthesia.
Offered Formulations and Strengths in the UK
The UK market offers numerous formulations of fentanyl citrate, developed to satisfy the differing needs of surgical and emergency situation departments. website are usually presented as clear, colourless solutions for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Typical Packaging | Maker Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Pack of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Pack of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU use) |
Note: While 50 mcg/ml is the standard concentration, specialised formulas for epidural or intrathecal use may sometimes be prepared by health center drug stores under specific protocols.
Pharmacokinetics and Pharmacodynamics
Comprehending how the body processes fentanyl is essential for safe administration.
- Start of Action: When administered intravenously, the effect begins practically immediately, though the maximal analgesic effect might take 3 to 5 minutes.
- Duration: A single intravenous dosage of 100 micrograms usually lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is mainly metabolised in the liver via the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, primarily as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and usually performed by anaesthetists or trained professionals in controlled environments.
Dose Guidelines
Dose must be horizontal and individualised based on the client's age, weight, physical status, underlying pathological condition, usage of other drugs, and the kind of surgical treatment.
- Low Dose (2 mcg/kg): Useful for small surgeries.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more invasive; needs respiratory monitoring.
- High Dose (20-- 50 mcg/kg): Used during "worry-free" significant surgeries (e.g., open-heart surgical treatment) to protect the myocardium from the metabolic needs of stress.
Paths of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer treatments or in the ICU.
- Intramuscular (IM): Less typical, but used for pre-medication in specific situations.
Regulatory Status and Safety
In the United Kingdom, Fentanyl is classified under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is classified as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be stored in a locked controlled drug cabinet.
- Record Keeping: Every administration needs to be tape-recorded in a Controlled Drugs Register (CDR).
- Destruction: Surplus or ended fentanyl should be denatured and seen by authorised personnel.
Adverse Effects and Adverse Reactions
While highly effective, fentanyl citrate carries a danger of substantial side results.
- Respiratory Depression: The most major side impact, which can cause breathing arrest if not kept track of.
- Bradychardia: Often managed with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation hard, requiring the use of neuromuscular obstructing representatives.
- Queasiness and Vomiting: Common in the postoperative period.
- Hypotension: Although more stable than morphine, it can still occur, particularly in hypovolaemic clients.
Contrast with Other Opioids
Clinicians often choose fentanyl over other opioids due to its specific pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Function | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Onset | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Negligible | Significant | Minimal |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Often Asked Questions (FAQ)
1. Is fentanyl citrate injection the like the fentanyl patches?
No. While they contain the very same active drug, the injection is for instant, acute usage in surgical or emergency settings. Patches (transdermal delivery) are designed for chronic, long-lasting discomfort management and release the medication gradually over 72 hours.
2. Can fentanyl citrate be utilized for children in the UK?
Yes, it is regularly utilized in paediatric anaesthesia. Nevertheless, the dosage needs to be strictly calculated based on the kid's weight, and they need to be kept an eye on carefully for breathing depression.
3. What is the antagonist for fentanyl?
Naloxone is the particular medicinal antagonist used to reverse the results of fentanyl, including respiratory depression. In UK health centers, naloxone should always be easily available anywhere fentanyl is administered.
4. Why is it utilized over morphine in heart surgical treatment?
Fentanyl is chosen in cardiac surgery due to the fact that it does not cause the release of histamine, which can cause vasodilation and hypotension. It offers cardiovascular stability even at high dosages.
5. What are the storage requirements?
Fentanyl citrate injection ought to be kept listed below 25 ° C and protected from light. As a Schedule 2 drug, it must be kept in a legally certified CD cupboard.
Fentanyl citrate injection formulas are important elements of the UK's medical toolkit for handling perioperative pain and helping with intricate surgeries. Its high effectiveness and rapid beginning deal unrivaled precision for anaesthetists, offered that extensive tracking and regulative requirements are preserved. By understanding the different concentrations and the stringent procedures surrounding its usage, health care specialists guarantee that this powerful medication stays both safe and efficient for clients across the nation.
Disclaimer: This short article is for informational purposes just and does not make up medical suggestions. Healthcare professionals should constantly describe the Summary of Product Characteristics (SmPC) and existing BNF guidelines for the most current prescribing details.
